Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment

Pretreatment with Bisphosphonate Enhances Osteogenesis of Bone Marrow Mesenchymal Stem Cells

(2017) Lei Hu et al.   STEM CELLS AND DEVELOPMENT

Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer

(2016) Mitsuru Futakuchi et al.   ADVANCED DRUG DELIVERY REVIEWS

Incidence rate for breast cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents

(2016) Kota Katanoda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases

(2016) Yoshiya Horimoto et al.   PLoS One

Systematic Literature Review and Network Meta-Analysis Comparing Bone-Targeted Agents for the Prevention of Skeletal-Related Events in Cancer Patients With Bone Metastasis

(2015) Z. Wang et al.   ONCOLOGIST

Cancer stem cells and tumor metastasis

(2014) SHUANG LI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma

(2014) Soufiane Boumahdi et al.   NATURE

Targeting the RANKL Pathway: Putting the Brakes on Prostate Cancer Progression in Bone

(2013) Isla P. Garraway   JOURNAL OF CLINICAL ONCOLOGY

Animal model for mammary tumor growth in the bone microenvironment

(2013) Mitsuru Futakuchi et al.   Breast Cancer

Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States

(2012) Min Yi et al.   CANCER

Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark

(2011) Annette Ø Jensen et al.   BMC CANCER

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

(2011) Catherine H. Van Poznak et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling

(2011) Wei Tan et al.   NATURE

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer

(2010) A Lugli et al.   BRITISH JOURNAL OF CANCER

Metastasis and bone loss: Advancing treatment and prevention

(2010) Robert E. Coleman et al.   CANCER TREATMENT REVIEWS

Transforming Growth Factor-β Coordinately Induces Suppressor of Cytokine Signaling 3 and Leukemia Inhibitory Factor to Suppress Osteoclast Apoptosis

(2010) Ming Ruan et al.   ENDOCRINOLOGY

Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK

(2010) Estabelle Ang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Zoledronic Acid Improves Clinical Outcomes When Administered Before Onset of Bone Pain in Patients With Prostate Cancer

(2010) Fred Saad et al.   UROLOGY

Guideline implementation for breast healthcare in low- and middle-income countries

(2009) Cheng-Har Yip et al.   CANCER

The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates

(2008) G. Sanna et al.   ACTA ONCOLOGICA

Cathepsin G Enhances Mammary Tumor-Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor- B Ligand

(2008) T. J. Wilson et al.   CANCER RESEARCH

Transforming growth factor β derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment

(2008) Shinya Sato et al.   CANCER SCIENCE

Transforming growth factor-β signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation

(2008) Mitsuru Futakuchi et al.   CANCER SCIENCE

Metastatic bone pain: treatment options with an emphasis on bisphosphonates

(2008) Roger von Moos et al.   SUPPORTIVE CARE IN CANCER